drug
as of 2026-07-01Moxonidine
MeSH C043482
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Baker Heart and Diabetes Institute
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Alleviating the Metabolic Side Effects of Antipsychotic Medications
NCT01567124Phase 4Withdrawn
KOLs & investigators
3
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
indication
indication
indication
KOL